Cardiac Monitors in Missouri

Turing Medical is a precision brain mapping and neuromodulation therapy company. The company develops PACE (Personalized Adaptive Cortical Electro-Stimulation), a precision-guided neuromodulation therapy platform designed to treat severe depression and chronic pain through adaptive cortical stimulation. PACE combines precision functional mapping with cortical stimulation, intended to restore healthy brain activity without the invasiveness of deep brain surgery—analogous to how a pacemaker restores cardiac rhythm. The company was formerly known as Nous Imaging and is led by co-founders Nico Dosenbach, M.D., PhD and Damien Fair, PA-C, PhD, both neuroscience researchers with published work in Nature on brain plasticity and precision functional mapping. Turing Medical's research focuses on reproducible brain-wide association studies, precision dynamical mapping, and mind-body network discovery. The company has appointed Kevin King, a medtech executive with three decades of experience in precision medicine and diagnostic technologies, as President and CEO as of April 2025, signaling expansion into clinical applications and commercialization. Turing Medical serves the neurology, psychiatry, and pain management markets. The company's technology platform leverages advanced functional brain imaging and mapping capabilities to enable personalized treatment targeting.

SafeBeat Rx is a digital health company specializing in AI-powered remote monitoring and therapeutic management for cardiac conditions, particularly atrial fibrillation (AFib) and heart failure. The SafeBeat Platform is a mobile-accessible system featuring proprietary ECG analysis algorithms and AI-driven clinical decision support tools designed for clinicians. The platform integrates data from FDA-cleared cardiac monitoring devices (mobile ECG, mobile cardiac telemetry, and implantable cardiac monitors) to deliver near real-time insights while minimizing alert fatigue. SafeBeat's explainable AI technology goes beyond diagnostics to guide therapeutic interventions, including personalized medication dosing and treatment recommendations. The company, founded in 2020 and led by cardiologist Dr. Rachita Navara and bioengineer Dr. Kunj Patel, focuses on improving healthcare access, reducing costs, and enhancing clinical workflows for cardiac care in hospital and remote monitoring settings.